These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 29253760

  • 1. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
    Yan H, Jung KH, Kim J, Rumman M, Oh MS, Hong SS.
    Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
    [Abstract] [Full Text] [Related]

  • 2. An ethyl acetate fraction of Artemisia capillaris (ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma.
    Jung KH, Rumman M, Yan H, Cheon MJ, Choi JG, Jin X, Park S, Oh MS, Hong SS.
    Phytother Res; 2018 Oct; 32(10):2034-2046. PubMed ID: 29972254
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
    Hui F, Qin X, Zhang Q, Li R, Liu M, Ren T, Zhao M, Zhao Q.
    Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
    [Abstract] [Full Text] [Related]

  • 5. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
    Hong SW, Jung KH, Lee HS, Choi MJ, Son MK, Zheng HM, Hong SS.
    Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393
    [Abstract] [Full Text] [Related]

  • 6. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M.
    Molecules; 2019 Jan 22; 24(3):. PubMed ID: 30678274
    [Abstract] [Full Text] [Related]

  • 7. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.
    Carcinogenesis; 2013 Jun 22; 34(6):1331-42. PubMed ID: 23393227
    [Abstract] [Full Text] [Related]

  • 8. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.
    Cancer Lett; 2012 Mar 28; 316(2):187-95. PubMed ID: 22182943
    [Abstract] [Full Text] [Related]

  • 11. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 28; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 12. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T, Wu X, Li Y, Lu W, Zheng F, Zhang C, Long Q, Qiu H, Li Y, Ge Q, Chen M, Yu X, Chen W, Zhang H, Huang W, Luo M, Deng W, Li L.
    Cell Physiol Biochem; 2018 Dec 28; 46(4):1365-1380. PubMed ID: 29689552
    [Abstract] [Full Text] [Related]

  • 13. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 28; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 14. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ, Mo YB, Bu X, Wang JJ, Bai J, Zhang JW, Cheng AB, Ma JH, Wang YW, Xie YX.
    Cell Physiol Biochem; 2018 Apr 28; 50(3):851-867. PubMed ID: 30355923
    [Abstract] [Full Text] [Related]

  • 15. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS, Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, Lu ZB, Yang HY, Yu LZ, Mo ZX, Yu ZL.
    Phytomedicine; 2019 Aug 28; 61():152843. PubMed ID: 31039533
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis.
    Jang E, Kim SY, Lee NR, Yi CM, Hong DR, Lee WS, Kim JH, Lee KT, Kim BJ, Lee JH, Inn KS.
    Oncol Rep; 2017 Jan 28; 37(1):526-532. PubMed ID: 28004112
    [Abstract] [Full Text] [Related]

  • 17. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L.
    J Biochem Mol Toxicol; 2021 Oct 28; 35(10):e22871. PubMed ID: 34338398
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J, Pi C, Wang G.
    Biomed Pharmacother; 2018 Jul 28; 103():699-707. PubMed ID: 29680738
    [Abstract] [Full Text] [Related]

  • 19. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
    Tahtouh R, Azzi AS, Alaaeddine N, Chamat S, Bouharoun-Tayoun H, Wardi L, Raad I, Sarkis R, Antoun NA, Hilal G.
    PLoS One; 2015 Jul 28; 10(3):e0119512. PubMed ID: 25822740
    [Abstract] [Full Text] [Related]

  • 20. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H, Zhang C, Xu L, Zang K, Ning Z, Jiang F, Chi H, Zhu X, Meng Z.
    Oncotarget; 2016 Apr 12; 7(15):20193-208. PubMed ID: 26958938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.